Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.

Original publication

DOI

10.1371/journal.pntd.0009522

Type

Journal

PLOS Neglected Tropical Diseases

Publisher

Public Library of Science (PLoS)

Publication Date

08/07/2021

Volume

15

Pages

e0009522 - e0009522